{"transactions":[{"id":807138,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2026-04-16T20:15:10.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":45266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2026, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":45266,"derivative":{"exercise_price":67.68,"expiration_date":"2036-04-14","underlying":"Common Stock","underlying_shares":45266},"source":{"system":"sec-edgar","filing":"0001193125-26-159029","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000119312526159029/ownership.xml","form_type":"4"}},{"id":1171039,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2025-04-16T20:15:12.000Z","date":"2025-04-15","kind":"grant","planned":false,"acquired":true,"shares":119922,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following April 15, 2025, the vesting commencement date, subject to the Report Person's continuous service to the Issuer through each vesting date."}],"balance_after":119922,"derivative":{"exercise_price":20.11,"expiration_date":"2035-04-14","underlying":"Common Stock","underlying_shares":119922},"source":{"system":"sec-edgar","filing":"0000950170-25-054738","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000095017025054738/ownership.xml","form_type":"4"}},{"id":1390186,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-10-07T20:56:24.000Z","date":"2024-10-04","kind":"grant","planned":false,"acquired":true,"shares":47775,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option vest monthly following October 4, 2024, the vesting commencement date, subject to the Reporting Person's continuous service to the Issuer through each vesting date."}],"balance_after":47775,"derivative":{"exercise_price":36.63,"expiration_date":"2034-10-03","underlying":"Common Stock","underlying_shares":47775},"source":{"system":"sec-edgar","filing":"0000950170-24-113290","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000095017024113290/ownership.xml","form_type":"4"}},{"id":1514360,"issuer":{"id":3735,"kind":"organization","name":"CG Oncology, Inc.","symbol":"CGON"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-05-16T22:57:39.000Z","date":"2024-05-15","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 25% of the underlying shares on June 1, 2025, and as to the remaining of the underlying shares in 36 substantially similar monthly installments thereafter."}],"balance_after":100000,"derivative":{"exercise_price":28.01,"expiration_date":"2034-05-14","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0000950170-24-061276","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000095017024061276/ownership.xml","form_type":"4"}},{"id":1661988,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"GENERAL COUNSEL"}}],"security":"Ordinary Shares","published_at":"2024-02-02T21:37:23.000Z","date":"2024-01-31","kind":"grant","planned":false,"acquired":true,"shares":480319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit award, and shall vest with respect to 33% of the RSUs, on each of  July 31, 2024 and July 31, 2025, respectively, and with respect to 34% of the RSUs, on July 31, 2026. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":855461,"source":{"system":"sec-edgar","filing":"0001415889-24-002308","document":"form4-02022024_090213.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000141588924002308/form4-02022024_090213.xml","form_type":"4"}},{"id":2022858,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2023-02-11T00:57:59.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":125860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"33% of the shares subject to the option award shall vest on each of August 8, 2023 and August 8, 2024, respectively, and 34% of the shares subject to the option award shall vest on August 8, 2025, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":125860,"derivative":{"exercise_price":1.59,"expiration_date":"2033-02-07","underlying":"Ordinary Shares","underlying_shares":125860},"source":{"system":"sec-edgar","filing":"0001209191-23-008564","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919123008564/doc4.xml","form_type":"4"}},{"id":2022857,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2023-02-11T00:57:59.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit award, and shall vest with respect to 33% of the RSUs, on each of August 8, 2023 and August 8, 2024, respectively, and with respect to 34% of the RSUs, on August 8, 2025. The vesting of the RSUs is subject to the Reporting Person's continuous service through each such vesting date."}],"balance_after":144000,"source":{"system":"sec-edgar","filing":"0001209191-23-008564","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919123008564/doc4.xml","form_type":"4"}},{"id":2419444,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Employee Share Option (Right to Buy)","published_at":"2022-02-01T21:23:25.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":77900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One fourth (1/4th) of the shares subject to the option award shall vest on January 28, 2023, and one twelfth (1/12th) of the remaining shares subject to the option award shall vest in equal quarterly installments thereafter, subject to the Reporting Person's continuous service through such vesting date."}],"balance_after":77900,"derivative":{"exercise_price":2.93,"expiration_date":"2032-01-27","underlying":"Ordinary Shares","underlying_shares":77900},"source":{"system":"sec-edgar","filing":"0001209191-22-005914","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919122005914/doc4.xml","form_type":"4"}},{"id":2419443,"issuer":{"id":94655,"kind":"organization","name":"Gamida Cell Ltd.","symbol":"GMDA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Ordinary Shares","published_at":"2022-02-01T21:23:25.000Z","date":"2022-01-28","kind":"grant","acquired":true,"shares":51000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":81000,"source":{"system":"sec-edgar","filing":"0001209191-22-005914","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919122005914/doc4.xml","form_type":"4"}},{"id":3008414,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-13T20:02:04.000Z","date":"2020-10-12","kind":"disposition_to_issuer","acquired":false,"shares":7500,"price":5.39,"value":40425.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option, which provided that 1/4th of the shares would vest one year after March 19, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $40,425.00, representing the difference between the exercise price of the option and the acquisition price of $18.15."}],"balance_after":0,"derivative":{"exercise_price":12.76,"expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-054618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120054618/doc4.xml","form_type":"4"}},{"id":3008413,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2020-10-13T20:02:04.000Z","date":"2020-10-12","kind":"disposition_to_issuer","acquired":false,"shares":13750,"price":1.16,"value":15950.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option, which provided that 1/4th of the shares would vest one year after January 2, 2020 and 1/48th of the shares would vest monthly thereafter over the next three years, was cancelled in connection with the merger of the Issuer with a wholly owned subsidiary of Ionis Pharmaceuticals, Inc. in exchange for a cash payment of $15,950.00, representing the difference between the exercise price of the option and the acquisition price of $18.15."}],"balance_after":0,"derivative":{"exercise_price":16.99,"expiration_date":"2030-01-01","underlying":"Common Stock","underlying_shares":13750},"source":{"system":"sec-edgar","filing":"0001209191-20-054618","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120054618/doc4.xml","form_type":"4"}},{"id":3008412,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-10-13T20:02:04.000Z","date":"2020-10-12","kind":"other","acquired":false,"shares":26532,"price":18.15,"value":481555.8,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001209191-20-054618","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120054618/doc4.xml","form_type":"4"}},{"id":3023033,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-09-24T20:25:42.000Z","date":"2020-09-22","kind":"sale","acquired":false,"shares":319,"price":18.12,"value":5780.28,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on September 19, 2019."}],"balance_after":26532,"source":{"system":"sec-edgar","filing":"0001209191-20-051894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120051894/doc4.xml","form_type":"4"}},{"id":3079654,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-07-20T21:18:34.000Z","date":"2020-07-17","kind":"sale","acquired":false,"shares":263,"price":12.5011,"value":3287.7893,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 15, 2020."}],"balance_after":26851,"source":{"system":"sec-edgar","filing":"0001209191-20-043062","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120043062/doc4.xml","form_type":"4"}},{"id":3176596,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-04-15T21:30:58.000Z","date":"2020-04-15","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan."}],"balance_after":27114,"source":{"system":"sec-edgar","filing":"0001209191-20-024511","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120024511/doc4.xml","form_type":"4"}},{"id":3195435,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-03-25T20:44:27.000Z","date":"2020-03-23","kind":"sale","acquired":false,"shares":335,"price":11.7555,"value":3938.0925,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Sale of shares of common stock to cover tax withholding obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on September 19, 2019."}],"balance_after":14614,"source":{"system":"sec-edgar","filing":"0001209191-20-021123","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120021123/doc4.xml","form_type":"4"}},{"id":3198111,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Stock Option (right to buy)","published_at":"2020-03-23T20:29:19.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":7500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares vest as follows: 1/4th of the shares vest one year after March 19, 2020;1/48th of the shares vest monthly thereafter over the next three years."}],"balance_after":7500,"derivative":{"exercise_price":12.76,"expiration_date":"2030-03-18","underlying":"Common Stock","underlying_shares":7500},"source":{"system":"sec-edgar","filing":"0001209191-20-020637","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120020637/doc4.xml","form_type":"4"}},{"id":3198110,"issuer":{"id":145982,"kind":"organization","name":"AKCEA THERAPEUTICS, INC.","symbol":"AKCA"},"owners":[{"id":52279,"kind":"person","name":"Patterson Joshua F.","position":1,"cik":"0001805702","reported_name":"Patterson Joshua F.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"General Counsel"}}],"security":"Common Stock","published_at":"2020-03-23T20:29:19.000Z","date":"2020-03-19","kind":"grant","acquired":true,"shares":3780,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit award granted under the Issuer's 2015 Equity Incentive Plan."}],"balance_after":14949,"source":{"system":"sec-edgar","filing":"0001209191-20-020637","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805702/000120919120020637/doc4.xml","form_type":"4"}}]}